Improved Drug Impurity ID Efficiency under CMC using 2-D LC/MS (Technical Report Vol.39)

The analytical method development section in CMC (Chemistry, Manufacturing andControl) department of pharmaceutical company constitutes part of the pharmaceutical developmental process that deals specifically with the physical nature of a drug substance and the drug product, how it is made, and the control of the manufacturing process to provide reliable and reproducible product. HPLC systems in these areas are utilized for the specification tests of active pharmaceutical ingredients (API) to insure the quality of the product as well as the level of impurities.

Content Type:
Application
Document Number:
C146-E149A
Product Type:
Mass Spectrometry, Liquid Chromatography, Liquid Chromatograph-Mass Spectrometry
Keywords:
CMC, Drug product, manufacturing process, API, QA/QC,2D-LC/MS, Pharmaceutical, Life Science, Drug synthesis and purification, DMPK, ADME, Safety testing, 2D-LC/MS Impurity ID System
Language:
English
File Name:
jpl212013.pdf
File Size:
2,540kb

View Article

For Research Use Only. Not for use in diagnostic procedures.

This page may contain references to products that are not available in your country. Please contact us to check the availability of these products in your country.

Top of This Page